Submit a manuscript Sign up for article alerts Contact us Support

About Clinical Sarcoma Research

This page includes information about the aims and scope of Clinical Sarcoma Research, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.

Aims & scope

Clinical Sarcoma Research publishes articles related to research on sarcomas, both of soft tissue and bone.

Clinical Sarcoma Research publishes original articles and review articles on diagnosis and treatment of sarcomas. It hosts new insights in sarcoma research, which may be of immediate or future interest for diagnosis and treatment. These include negative results, especially from studies on new agents. In fact, it is vital for the medical community to learn whether new agents have proven effective or ineffective, all the more in subtypes of sarcomas, thus avoiding any publication bias. The journal also aims to offer a forum for active discussion on topics of major interest for the sarcoma community. This may affect both research results and methodological topics.

Open access

All articles published by Clinical Sarcoma Research are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

Authors of articles published in Clinical Sarcoma Research are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.

For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article-processing charges

Open access publishing is not without costs. Clinical Sarcoma Research therefore levies an article-processing charge of £1240/$1940/€1580 for each article accepted for publication. If the corresponding author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.

Indexing services

All articles published in Clinical Sarcoma Research are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Clinical Sarcoma Research include:

  • CAS
  • DOAJ
  • PubMed
  • PubMed Central

The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).

The full text of all research articles published by BioMed Central is also available on SpringerLink.

BioMed Central is working closely with Thomson Reuters (ISI) to ensure that citation analysis of articles published in Clinical Sarcoma Research will be available.

Publication and peer review process

Criteria for publication

Clinical Sarcoma Research considers the following types of articles:

  • Research - reports of data from original research.
  • Case reports - reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction.
  • Methodology articles - present a new experimental method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method.
  • Reviews - comprehensive, authoritative, descriptions of any subject within the scope of Clinical Sarcoma Research. These articles are usually written by opinion leaders that have been invited by the Editorial Board.
  • Short reports - brief reports of data from original research.
  • Letter to the Editor - These can take several forms. For example, a substantial critique or re-analysis of a previously published article, a substantial response to such a re-analysis from the authors of the original publication, or an article that may not cover 'standard research' but that may be relevant to readers. Please consult the Editor prior to submission if in doubt.
  • Meeting reports - a short description of a conference that the author has attended, which focuses on the key developments presented and discussed at the meeting.

Peer-review policies

A closed peer review process will be in place for all original research and review articles. Submission will be screened by the Editors-in-Chief and, if appropriate, sent to an Editorial Board Member, who will manage the peer review. Two reviewers will be consulted for each manuscript. All final decisions will be taken by the Editors-in-chief considering the evaluation of the reviewers. The need to avoid any publication bias will lead the Editorial board to assist researchers in the publication of negative results. The Editors-in-Chief will be responsible for decisions on Editorials/Commentaries.

Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Clinical Sarcoma Research, a personalized section of the site.


High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.


Clinical Sarcoma Research will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.

Editorial policies

All manuscripts submitted to Clinical Sarcoma Research should adhere to BioMed Central's editorial policies.

Citing articles in Clinical Sarcoma Research

Articles in Clinical Sarcoma Research should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Clin Sarcoma Res [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Clin Sarcoma Res 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Why publish your article in Clinical Sarcoma Research?

High visibility

Clinical Sarcoma Research's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.

Speed of publication

Clinical Sarcoma Research offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Clinical Sarcoma Research, BioMed Central and PubMed Central and will also be included in PubMed.


Online publication in Clinical Sarcoma Research gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Clinical Sarcoma Research are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Clinical Sarcoma Research's pages and on the BioMed Central homepage.

In addition, articles published in Clinical Sarcoma Research may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Clinical Sarcoma Research. A list of articles recently press-released by journals published by BioMed Central is available here.

Authors of articles published in Clinical Sarcoma Research retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright policy and license agreement).

For further information about the advantages of publishing in a journal from BioMed Central, please click here.